Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

2013 ACR/ARHP Annual Meeting: Genetic Research Yields Clues to Pathogenesis of Rheumatoid Arthritis, Psoriatic Arthritis

Mary Beth Nierengarten  |  January 1, 2014

Studies determine that both RA and PsA are autoimmune diseases and link disease susceptibility to certain alleles that encode the major histocompatibility complex, HLA

2013 ACR/ARHP Annual Meeting: Researchers Explore Role of Pathogens, Quality of Care in Rheumatoid Arthritis

Mary Beth Nierengarten  |  January 1, 2014

Funding by the Rheumatology Research Foundation has furthered studies on the impact of infectious agents and autoantigens, periodontal disease, and disease-modifying antirheumatic drugs on patients with RA

2013 ACR/ARHP Annual Meeting: New Tools to Measure Quality in Rheumatology

Susan Bernstein  |  January 1, 2014

Rising healthcare costs, shifting market forces will require rheumatologists to adapt new quality measurement techniques, more effective patient care models, better rheumatology registries

2013 ACR/ARHP Annual Meeting: Health Professionals In the Spotlight

Richard Quinn  |  January 1, 2014

ARHP members are honored with awards for research, education, advocacy, and patient care in rheumatology

ACR Aims to Keep Rheumatology on Congressional Radar in 2014

Staff  |  January 1, 2014

Ongoing advocacy by the ACR will target repealing SGR legislation, halting the implementation of ICD-10 coding and billing changes, and enlisting support for the Patients’ Access to Treatments Act

2014 Pediatric Rheumatology Symposium To Focus on Closing Gap Between Clinical Experience, Practice

Staff  |  January 1, 2014

Annual conference to be held April 3–6 in Orlando, Fla.

Rheuminations: Why the Obesity Epidemic Should Matter to Rheumatologists

Simon M. Helfgott, MD  |  January 1, 2014

As changes in diet and eating habits have caused obesity rates to soar, research into the metabolic syndrome suggests obesity may be a form of a low-grade inflammatory state

Affordable Care Act By The Numbers

Bryn Nelson, PhD  |  January 1, 2014

Predicted impact of government spending under Obamacare tells story of winners, losers in the healthcare reform effort

How Obamacare Is Expected to Impact Rheumatologists and Their Patients

Bryn Nelson, PhD  |  January 1, 2014

Provisions of the Affordable Care Act may affect Medicare patient co-pays for high-priced drugs, alleviate the shortage of pediatric rheumatologists, and encourage greater coordination among specialty providers

  • « Previous Page
  • 1
  • …
  • 234
  • 235
  • 236
  • 237
  • 238
  • …
  • 308
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences